Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells-Reference-Cited by-同舟云学术

Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells

Published:2020-09-15 Issue:11 Volume:17 Page:1655-1669
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Haggag Yusuf¹,Abu Ras Bayan²,El-Tanani Yahia²,Tambuwala Murtaza M.³^ORCID,McCarron Paul³,Isreb Mohammed²,El-Tanani Mohamed⁴⁵

Affiliation:

1. Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta, Egypt

2. School of Pharmacy and Clinical Sciences, University of Bradford, Bradford, UK

3. School of Pharmacy and Pharmaceutical Sciences, Ulster University, UK

4. Pharmacological and Diagnostic Research Centre, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan

5. Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford, UK

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2020.1813714

Reference65 articles.

1. Cancer as an evolutionary and ecological process

2. Cancer statistics, 2019

3. Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma

4. Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

5. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-based in-silico identification of natural compounds as potential inhibitors of ran GTPase for breast cancer treatment;Biocatalysis and Agricultural Biotechnology;2024-09

2. New uracil analog as inhibitor/modulator of ABC transporters or/and NF-κB in taxol-resistant MCF-7/Tx cell line;Journal of Cancer Research and Clinical Oncology;2024-06-25

3. Recent advanced lipid-based nanomedicines for overcoming cancer resistance;Cancer Drug Resistance;2024-06-21

4. Targeting guanine nucleotide exchange factors for novel cancer drug discovery;Expert Opinion on Drug Discovery;2024-06-17

5. Microfluidics-mediated Liposomal Nanoparticles for Cancer Therapy: Recent Developments on Advanced Devices and Technologies;Current Topics in Medicinal Chemistry;2024-05